Comments
Natco Pharma has registered a net profit of Rs 17 crore for the quarter ended December 31, 2011, marginally up from Rs 15.94 crore in the comparative quarter.
According to unaudited results announced on Thursday, turnover was up 9 per cent at Rs 145 crore (Rs 133 crore) during the quarter under review. The growth has been driven by increased sale of active pharmaceutical intermediates and formulation exports.
The company's board has recommended an interim dividend of Rs 3 per share (Rs 2 per share during 2010), according to a company press release.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.